UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Extended scope of the patent term extension South Korea follows Japan: ‘substantially identical’ scope is ‘extended’

Pharmaceutical patent analyst, 2019-05, Vol.8 (3), p.71-72

Komatani, Takeshi S

2019

Volltextzugriff (PDF)

The German Federal Supreme Court also granted a compulsory patent license for the first time in its history

Pharmaceutical patent analyst, 2017-11, Vol.6 (6), p.255-256

Komatani, Takeshi S

2017

Volltextzugriff (PDF)

Upcoming challenges in intellectual property presented by emerging pharmaceutical technologies

Pharmaceutical patent analyst, 2017-01, Vol.6 (1), p.1-4

Komatani, Takeshi S

2017

Volltextzugriff (PDF)

Doctrine of equivalents in Japan - criteria of special conditions and estoppel: final conclusion

Pharmaceutical patent analyst, 2017-11, Vol.6 (6), p.257-258

Komatani, Takeshi S

2017

Volltextzugriff (PDF)

January 2017 extended scope of patent term extension: Japan is progenerics Debiopharm - International SA vs Towa Pharmaceutical Co. Ltd

Pharmaceutical patent analyst, 2017-05, Vol.6 (3), p.95-96

Komatani, Takeshi S

2017

Volltextzugriff (PDF)

Patent and intellectual property rights related to pharmaceuticals: global future perspectives: Japan

Pharmaceutical patent analyst, 2016-07, Vol.5 (4), p.227-235

Komatani, Takeshi S

2016

Volltextzugriff (PDF)

Pharmaceutical patent law: expert perspectives from around the globe

Pharmaceutical patent analyst, 2016-07, Vol.5 (4), p.195-197

Komatani, Takeshi S

2016

Volltextzugriff (PDF)

Is inherent disclosure sufficient for priority claim? Monoclonal versus chimeric/humanized antibody: estoppels

Pharmaceutical patent analyst, 2016-11, Vol.5 (6), p.375-376

Komatani, Takeshi S

2016

Volltextzugriff (PDF)

Patenting drug delivery technology: tips for formulating practical and effective patent portfolio

Pharmaceutical patent analyst, 2016-01, Vol.5 (2), p.97-100

Komatani, Takeshi S

2016

Volltextzugriff (PDF)

Doctrine of equivalents in Japan: criteria of special conditions and estoppel

Pharmaceutical patent analyst, 2016-05, Vol.5 (3), p.157-158

Komatani, Takeshi S

2016

Volltextzugriff (PDF)

November 2015: patent term extension: the Supreme Court of Japan gave an answer to the question and the JPO now has to prepare new examination guidelines

Pharmaceutical patent analyst, 2016-05, Vol.5 (3), p.155-156

Komatani, Takeshi S

2016

Volltextzugriff (PDF)

Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?

Pharmaceutical patent analyst, 2015-01, Vol.4 (5), p.357-362

Komatani, Takeshi S

2015

Volltextzugriff (PDF)

Cases Update June 2015: Product By Process – Sparkling Or Stumbling Decision Issued By Supreme Court of Japan

Pharmaceutical patent analyst, 2015-11, Vol.4 (6), p.421-422

Komatani, Takeshi S

2015

Volltextzugriff (PDF)

Intellectual property strategy for regenerative medicine: is it time to 'regenerate'?

Pharmaceutical patent analyst, 2014-09, Vol.3 (5), p.475-479

Komatani, Takeshi S

2014

Volltextzugriff (PDF)

Intellectual property protection of molecules/proteins/genes/natural products: will recent case law change patent practice in the pharmaceutical industry?

Pharmaceutical patent analyst, 2015-01, Vol.4 (3), p.135-139

Komatani, Takeshi S

2015

Volltextzugriff (PDF)

Scope of protection of a patent directed to prodrugs, metabolites and the like

Pharmaceutical patent analyst, 2014, Vol.3 (6), p.567-570

Komatani, Takeshi S

2014

Volltextzugriff (PDF)

Changes in global pharmaceutical patent strategy due to intergovernmental cooperation

Pharmaceutical patent analyst, 2014-03, Vol.3 (2), p.133-136

Komatani, Takeshi S

2014

Volltextzugriff (PDF)

A study of crystal lattice fringe observation using the 30kV STEM

Microscopy and microanalysis, 2012-07, Vol.18 (S2), p.372-373

Takeshi, S.

2012

Volltextzugriff (PDF)

Patent term extension in Japan: challenges still lay ahead even after the 2011 revision

Pharmaceutical patent analyst, 2013-01, Vol.2 (1), p.63-76

Komatani, Takeshi S

2013

Volltextzugriff (PDF)

Challenges to obtaining good pharmaceutical patents in Japan: 2009 and beyond

Pharmaceutical patent analyst, 2013-05, Vol.2 (3), p.325-340

Komatani, Takeshi S

2013

Volltextzugriff (PDF)

Association of University Technology Managers Asia 2013 conference

Pharmaceutical patent analyst, 2013-07, Vol.2 (4), p.447-449

Komatani, Takeshi S

2013

Volltextzugriff (PDF)

Cases Update: International Roundup of Recently Filed Cases and Noteworthy Rulings

Pharmaceutical patent analyst, 2014-03, Vol.3 (2), p.137-141

2014

Volltextzugriff (PDF)

Cases Update: International Roundup of Recently Filed Cases and Noteworthy Rulings

Pharmaceutical patent analyst, 2013-09, Vol.2 (5), p.597-601

2013

Volltextzugriff (PDF)

Cases Update

Pharmaceutical patent analyst, 2013-03, Vol.2 (2), p.181-186

2013

Volltextzugriff (PDF)

Carbon Nanotubes: Applications in Pharmacy and Medicine

BioMed research international, 2013-01, Vol.2013 (2013), p.1-12

2013

Volltextzugriff (PDF)

1 – 25 von 238.075

Menü

Weitere Dienste

Einstellungen

Extended scope of the patent term extension South Korea follows Japan: ‘substantially identical’ scope is ‘extended’

The German Federal Supreme Court also granted a compulsory patent license for the first time in its history

Upcoming challenges in intellectual property presented by emerging pharmaceutical technologies

Doctrine of equivalents in Japan - criteria of special conditions and estoppel: final conclusion

January 2017 extended scope of patent term extension: Japan is progenerics Debiopharm - International SA vs Towa Pharmaceutical Co. Ltd

Patent and intellectual property rights related to pharmaceuticals: global future perspectives: Japan

Pharmaceutical patent law: expert perspectives from around the globe

Is inherent disclosure sufficient for priority claim? Monoclonal versus chimeric/humanized antibody: estoppels

Patenting drug delivery technology: tips for formulating practical and effective patent portfolio

Doctrine of equivalents in Japan: criteria of special conditions and estoppel

November 2015: patent term extension: the Supreme Court of Japan gave an answer to the question and the JPO now has to prepare new examination guidelines

Patent protection of diagnostic technology: will recent US Supreme Court decisions change patent strategy?

Cases Update June 2015: Product By Process – Sparkling Or Stumbling Decision Issued By Supreme Court of Japan

Intellectual property strategy for regenerative medicine: is it time to 'regenerate'?

Intellectual property protection of molecules/proteins/genes/natural products: will recent case law change patent practice in the pharmaceutical industry?

Scope of protection of a patent directed to prodrugs, metabolites and the like

Changes in global pharmaceutical patent strategy due to intergovernmental cooperation

A study of crystal lattice fringe observation using the 30kV STEM

Patent term extension in Japan: challenges still lay ahead even after the 2011 revision

Challenges to obtaining good pharmaceutical patents in Japan: 2009 and beyond

Association of University Technology Managers Asia 2013 conference

Cases Update: International Roundup of Recently Filed Cases and Noteworthy Rulings

Cases Update: International Roundup of Recently Filed Cases and Noteworthy Rulings

Cases Update

Carbon Nanotubes: Applications in Pharmacy and Medicine

Suchergebnisse filtern